Journal of Hematology & Oncology 2019

1 papers

Top Research Directions

The 4 research directions with Journal of Hematology & Oncology 2019 papers, ranked by paper count, next to 2018. Share is the fraction of the edition’s papers in the direction.

#Direction20192018Share 2019Share 20182018 rank
1Bidirectional Functional Validation of Gene Expression in Disease Models10100.0%0.0%—
2Generalizability Limitations of Single Center Retrospective Studies10100.0%0.0%—
3Identifying Molecular Vulnerabilities for Tumor Growth Suppression10100.0%0.0%—
4Molecular Cascades Driving Cancer Metastasis10100.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Hematology & Oncology 2019 papers: a paper credits every institution named in its affiliations, once. 2 institutions share 1 credited papers.

#InstitutionPapersShare20182018 rank
1Brown University 1100.0%0—
2Rhode Island Hospital 1100.0%0—

Download all institutions as CSV

About this data

Papers. Journal of Hematology & Oncology 2019 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2018 use shares, since the edition went from 2 to 1 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Hematology & Oncology 2019”, https://lacuna.tiptreesystems.com/venue/journal-of-hematology-oncology/2019.

Papers

Title
Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway